Clinical Trials
Discover the future of medicine today. Yale Medicine currently offers 687 active clinical trials across our hospitals and care centers, providing our patients with early access to many of the world’s most advanced therapies. Yale Center for Clinical Investigation (YCCI) supports, coordinates, and oversees clinical trials, ensuring the safety of trial volunteers.
For more information about cancer-related trials, call us at 203-785-5702. For all other trials, call 877-978-8343.
10 Results
Chronic Hypertension and Pregnancy (CHAP) Project (CHAP)
- Pregnancy & Obstetrics
- Hypertension
- Gender:Female only
- Age:12 years and older
A Phase II, Multicenter, Prospective Study of Sacituzumab Govitecan in Recurrent Glioblastoma
- Brain & Other Nervous System Cancers
Iadademstat and Radiation Therapy With Atezolizumab in Extensive Stage Small-cell Lung Cancer (ES-SCLC) Patients With Persistent, Recurrent or Progressive Disease After First Line Systemic Therapy
- Lung Cancer
A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (Dara-VCD) Induction Followed by Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients With Newly Diagnosed AL Amyloidosis
- Leukemia & Hematologic Cancers
A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Neoplasms
- Thyroid & Other Endocrine Cancers
- Phase 1 Cancers
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II (COSIRA-II)
- Heart/Cardiovascular
- Gender:All Genders
- Age:18 years and older
A Phase 2/3, Multicenter, Randomized Study of Raludotatug Deruxtecan (R-DXd), a CDH6-directed Antibody-drug Conjugate, in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Gynecological Cancers
- Gender:Female only
- Age:18 years and older
A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Advanced or Metastatic Solid Tumors
- Stomach & Esophagus
- Gastrointestinal Cancers
- Pancreatic Cancer
- Colorectal Cancer
- Phase 1 Cancers
A Phase III Study of Targeted Therapy vs. Chemotherapy in Patients with Thyroid Cancer
- Thyroid & Other Endocrine Cancers
- Gender:All Genders
- Age:18 years and older
SELECT: A Phase II Adjuvant Trial Evaluating the Impact of Omitting Chemotherapy Based on Patient's Selection for Moderate to High-Anatomical Risk, Low-Genomic Risk, ER-Positive, HER2- Negative Breast Cancer With a Combination Regimen of Ribociclib and Optimized Endocrine Therapy
- Breast Cancer